If you have been told your lumpy, tender, painful breasts are "just fibrocystic" and that there is nothing to be done — the published clinical record says otherwise. A 1,365-patient trial demonstrated that topical molecular iodine produced objective improvement in 65 to 74 percent of women. This site exists to make that evidence, and the product that delivers it, genuinely accessible.
Straightforward information about what fibrocystic breast disease is, why it happens, and how a simple topical gel — applied once daily — can address the underlying tissue biology rather than just the pain.
The peer-reviewed evidence base, the pharmacokinetic rationale for topical molecular iodine, the FBD–ADH continuum, and the mechanism by which iodine normalizes estrogen-sensitive breast tissue — with full citations.
Ghent W, Eskin B, et al. Canadian Journal of Surgery, 1993; 36:453–460.
Tomlinson-Hansen SE, Khan M, Cassaro S. StatPearls, NIH/NCBI, updated 2023.